Madeleine Pettersson Bergstrand

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2022;130(4):492-500
Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity
Arvidsson M; Franck J; Ackehed G; Bergstrand MP; Ekstrom L; Rosenborg S; Dahl M-L
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2019;411(19):4751-4763
In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR
Article: CLINICAL TOXICOLOGY. 2019;57(3):203-212
Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project
Backberg M; Bergstrand MP; Beck O; Helander A
Article: DRUG TESTING AND ANALYSIS. 2019;11(1):45-50
In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
Article: CLINICAL MASS SPECTROMETRY. 2018;10:25-32
Urine analysis of 28 designer benzodiazepines by liquid chromatography-high-resolution mass spectrometry
Bergstrand MP; Beck O; Helander A
Article: DRUG TESTING AND ANALYSIS. 2018;10(3):496-506
Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry
Bergstrand MP; Meyer MR; Beck O; Helander A
Article: DRUG TESTING AND ANALYSIS. 2017;9(4):640-645
Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays
Bergstrand MP; Helander A; Hansson T; Beck O
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2016;1035:104-110
Development and application of a multi-component LC-MS/MS method for determination of designer benzodiazepines in urine
Bergstrand MP; Helander A; Beck O
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2016;408(13):3571-3591
Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes
Meyer MR; Bergstrand MP; Helander A; Beck O

Alla övriga publikationer

Thesis / dissertation: 2018
Bioanalytical studies of designer benzodiazepines
Pettersson Bergstrand, Madeleine

Anställningar

Anknuten till Forskning, Laboratoriemedicin, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2018

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI